NovaUCD - Making an Impact Since 2003

Page 1

NovaUCD Making an Impact Since 2003 NovaUCD - Centre for New Ventures and Entrepreneurs NovaUCD - Ionad d’Fhiontair Nua agus d’Fhiontraithe

Produced by UCD Research and Innovation


Contents Foreword by Professor Orla Feely, UCD Vice-President for Research, Innovation and Impact

4

Foreword by Tom Flanagan, UCD Director of Enterprise and Commercialisation

5

Introducing NovaUCD, the Centre for New Ventures and Entrepreneurs

6

Making an Impact

8

Facilities and Programmes to Support and Scale Start-Up Companies

10

Support Programmes for Researchers and Students

12

Linking with Business and Industry

14

Knowledge Transfer

16

Staff Members

18

Location and Directions

19

Appendices 1. Timeline of key milestones

20

2. Success Stories

22

3. Client Companies

26

4. Alumni Companies

27

5. Winners of the UCD VentureLaunch Accelerator Programme

28

6. Recipients of the NovaUCD Innovation Award

30

April 2019

2

UCD is committed to its key role in Ireland’s innovation and knowledge exchange ecosystem as an enabler of economic growth and as a contributor to economic, cultural and social development.


NovaUCD Making an Impact €760+ million

Equity Funding Raised

2,100

Direct and Indirect Jobs Suppo ed

825+

Inventions Disclosed

€150+ million Value of 3 Major Exits

360+

Companies and New Ventures Suppo ed

280+

Priority Patents Filed

€113+ million

Current Annual Turnover

45

UCD Spin-outs Incorporated

200+

Licence Agreements Concluded Data 2003-2018

3


Foreword by Professor Orla Feely, UCD Vice-President for Research, Innovation and Impact

University College Dublin is committed to its key role in Ireland’s innovation and knowledge exchange ecosystem as an enabler of economic growth and as a contributor to economic, cultural and social development. We support this commitment through our innovative and entrepreneurial students and graduates, the development of partnerships with businesses, Government agencies and social and cultural enterprises, and through NovaUCD. NovaUCD is focused on the commercialisation of research outputs, creating new ventures, supporting and scaling start-ups and established companies, and creating jobs. Fifteen years ago the university created a world-class, purpose-built incubation facility based around one of its historic Georgian buildings, then known as Merville House, subsequently rebranded as NovaUCD. Since then NovaUCD has developed an excellent infrastructure, a range of comprehensive support programmes and a peer-support system that nurtures an enthusiastic and dynamic community of talented entrepreneurs at NovaUCD and across the university campus. UCD’s continued commitment to the activities of NovaUCD was demonstrated last August by the announcement that the university is investing €6.5 million to develop and extend the facility’s east courtyard. NovaUCD was originally funded through a unique public-private partnership and was the brainchild of its first director Dr Pat Frain. His foresight was supported by the founding sponsors: AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx. We are also very appreciative of the continuing support provided by Enterprise Ireland through the Technology Transfer Strengthening Initiative, managed by Knowledge Transfer Ireland.

4

NovaUCD’s achievements to date are shown, in part, by the strong results from our 15 year survey featured in this publication. Highlights of the results include: • NovaUCD-supported companies currently directly employ over 1,040, more than 950 of whom are based in Ireland. • The combined current annual turnover of NovaUCD-supported companies is in excess of €113 million and, to date, they have raised over €760 million in equity funding. NovaUCD is also the home of UCD’s knowledge transfer team, and the success in this area since 2003 is equally compelling: • Over 825 inventions have been disclosed and over 280 priority patent applications filed. • Over 200 licensing deals have been concluded with a range of indigenous and international businesses. • 45 spin-out companies have been incorporated. I would like to thank the community of entrepreneurs and researchers across the UCD campus who have been supported through NovaUCD, whose expertise, hard work and commitment provides the raw material without which none of these results would happen. This success is also due in no small part to the highly skilled and dedicated staff who have worked at NovaUCD since 2003.

Professor Orla Feely UCD Vice-President for Research, Innovation and Impact


Foreword by Tom Flanagan, UCD Director of Enterprise and Commercialisation

Looking forward there are a great many opportunities for NovaUCD to build on its successes to make a real difference in the innovation landscape in Ireland. NovaUCD has been making an impact ever since it opened in 2003 and we are very proud of our achievements, some of which are outlined in this Report. We now look forward to building on the successful formula for enterprise development and commercialisation that we have shaped over the last 15-years. NovaUCD has been running at full capacity for several years now and there is an ongoing and significant demand from ambitious entrepreneurs who want to locate their start-ups at NovaUCD to leverage our ecosystem of experienced mentors, founders, alumni, investors and sponsors who can help them grow their businesses globally. This demand was the impetus for the exciting €6.5 million project to develop and extend NovaUCD’s east courtyard which commenced in the summer of 2018. This development has resulted in 800m2 of additional licensable space and has enabled us to significantly increase our capacity to house start-up companies by over 50%. The additional space is enabling our community of entrepreneurs, who want to start, grow and scale companies with global market potential, to flourish. We have already developed a number of successful programmes to support the commercialisation of research outputs and to assist with start-up creation and growth, such as the Commercialisation Bootcamps, the Start-Up Stars Programme for student entrepreneurs and the VentureLaunch Accelerator Programme. We are now planning on rolling out several new programmes which will tie NovaUCD, and the university, more closely to sectors with high-growth potential such as 5G/IoT, agtech and medtech.

In terms of 5G/IoT we are currently partnering with Vodafone and Ericsson to deliver Ireland’s first dedicated 5G/IoT Accelerator Programme. Through this 10week programme, which will be held at NovaUCD, we will work with dynamic teams who have the potential and drive to bring new 5G/IoT-network enabled products and services to market. We intend to introduce similar accelerator programmes in agtech, to leverage the expertise and resources at UCD’s Lyons Research Farm in Co. Kildare, and also in medtech. We will also build on recent initiatives such as the opening of in-hospital knowledge transfer offices. The purpose of these offices is to enable NovaUCD staff meet onsite with clinicians in St. Vincent’s Healthcare Group and in The Mater Misericordiae University Hospital, to review their ideas and inventions and to help them progress these opportunities all the way through to becoming a start-up. The university has also announced ambitious plans to recruit a significant number of additional talented academics over the next five years. This recruitment drive will strengthen our community and help to increase the quality, quantity and impact of our research and innovation outputs. Given these and other developments NovaUCD has a very bright future indeed. Tom Flanagan UCD Director of Enterprise and Commercialisation

5


Introducing NovaUCD, the Centre for New Ventures and Entrepreneurs NovaUCD, located in a magnificent mid-18th-century house, formerly known as Merville House, has been the hub for new ventures and entrepreneurs at University College Dublin since 2003. NovaUCD is a purpose-built, state-of-the-art facility for high-tech and knowledgeintensive start-up companies. At NovaUCD a comprehensive business support programme for client companies is also provided. This programme comprises advice, seminars and workshops as well as facilitated access to the NovaUCD network of university researchers, business leaders and investors. At NovaUCD a highly networked community of entrepreneurs provides an environment for start-up founders to share their experiences to assist other startups to develop and grow. This innovative and entrepreneurial community, along with the wider NovaUCD network, creates an invaluable support for client companies. The original concept for NovaUCD, designed by Kavanagh Tuite Architects, was to restore the original house as the centrepiece of a complex of subsidiary buildings that surround it. The buildings are bright, airy and open with high-quality shared and circulation spaces that encourage the formal and informal interactions necessary for the development of a community of entrepreneurs. The conversion to a modern centre for new ventures and entrepreneurs was funded by a unique public-private partnership which was established by Dr Pat Frain, the then Director of NovaUCD. Six private sector sponsors; AIB Bank, Arthur Cox, Deloitte, Ericsson, Goodbody Stockbrokers, and Xilinx, contributed 75% of the €10 million raised to develop the first two phases of the NovaUCD complex.

6

These sponsors were chosen to bring an appropriate mix of expertise and experience to the support programmes offered at NovaUCD. The balance of funds for the first two phases was contributed by Enterprise Ireland and the university. Additional funding of €1.3 million was provided by Enterprise Ireland and UCD for bio-incubation facilities and equipment to accommodate biotechnology start-up companies. NovaUCD was officially opened by An Tánaiste and Minister for Enterprise, Trade and Employment, Mary Harney TD, in October 2003.

Pictured (l-r) at the official opening of NovaUCD in 2003 are; John Kelly, AIB Bank, Feargal Ó’Móráin, Enterprise Ireland, Dr Art Cosgrove, President, UCD; Mark O’Donovan, Goodbody Stockbrokers; An Tánaiste, Ms Mary Harney TD; Pádraig Ó’Ríordáin, Arthur Cox; Ian Cahill, Ericsson, Paul McCambridge, Xilinx, Pat Kenny, Deloitte and Dr Pat Frain, Director, NovaUCD

In August 2018 UCD announced that it is expanding NovaUCD’s capacity to house start-ups by over 50% with a €6.5 million development project. The project, led by Kavanagh Tuite Architects, to renovate and extend the facility’s east courtyard is expected to be completed in Summer 2019. See Appendix 1 which outlines a timeline of key milestones of UCD’s support for commercialisation and entrepreneurship since the establishment of the University Industry Centre, the forerunner to NovaUCD, in 1985 to date.


NovaUCD Client Companies Over 50 innovative start-ups are currently supported by NovaUCD. See examples of success stories highlighted in Appendix 2. Many of these are spin-out companies which are commercialising research specifically undertaken at UCD. The remaining are spin-in companies which have located on campus in order to interact more closely with the university, see Appendix 3. It is an important element of our strategy to continuously refresh the community of entrepreneurs at NovaUCD and to have the capacity at all times to take on new projects. Examples of NovaUCD alumni companies are included in Appendix 4.

7


Making an Impact Since 2003, UCD has provided support to 360+ companies and early-stage ventures through the services and supports provided across UCD, through NovaUCD, and through business support programmes run and managed by NovaUCD. Between them these companies currently support 1,040+ jobs directly, of which 950+ are based in Ireland, and together these companies have raised over €760 million in equity funding to date, and have a current annual turnover in excess of €113 million. UCD’s knowledge transfer team, which is responsible for the commercialisation of the intellectual property emerging from UCD’s world-class research programmes, is also based at NovaUCD. Since 2003 45 new UCD spin-out companies have been incorporated; over 825 inventions have been disclosed by UCD researchers; over 280 priority patent applications have been filed and over 200 licensing deals have been concluded with a range of indigenous and international businesses such as, Amdocs, Amryt and Glanbia.

8

Julie Sinnamon, CEO, Enterprise Ireland and Tom Flanagan, UCD Director of Enterprise and Commercialisation


NovaUCD – Key Economic Impact Data (2003-2018) Companies supported • 360+: Number of companies and early-stage ventures supported • 45: Number of UCD spin-out companies incorporated

Employment • 1,040+: Total number currently employed* by NovaUCD supported companies • 950+: Total number currently employed in Ireland by NovaUCD supported companies

Equity Funding and Turnover • €760+ million: Combined equity funding raised to date by NovaUCD supported companies • €150+ million: Value of 3 major exits • €113+ million: Combined current annual turnover of NovaUCD supported companies

Commercialisation activities • 825+: Inventions disclosed • 280+: Priority patents filed • 200+: Licence agreements concluded

* Using a multiplier of 2 would indicate that NovaUCD companies are supporting approximately 2,100 jobs in total, some 1,040 jobs indirectly in addition to over 1,040 direct jobs.

The key economic impact data of NovaUCD supported companies for the period 2003-2018 are based on the following information sources; publically available information; a survey of companies carried out during 2018 with a ca. 70% response rate; supplemented with data from a previous survey of companies (2013). Data on commercialisation income and knowledge transfer related metrics are maintained directly by the NovaUCD team.

9


Facilities and Programmes to Support and Scale Start-Up Companies University College Dublin now has a proven track record in supporting entrepreneurs and new ventures on campus at NovaUCD, from the early feasibility stage, through to business development, investment and scaling. Co-working, Business and Laboratory Facilities The buildings at NovaUCD are bright, airy and open with high-quality shared and circulation spaces that encourage the informal and formal interactions necessary for the development of a community of entrepreneurs. At NovaUCD a wide range of flexible occupancy options including; co-working space and offices are provided to entrepreneurs to enable them to move as their businesses grow and develop. A limited number of the offices can be configured to laboratory space. Additional Facilities and Services At NovaUCD, which has 24/7 access, additional facilities and services include; reception services, a permanent boardroom, seminar and meeting rooms, a dedicated video conferencing room, wireless network, a dedicated server room and a café with an external deck. Support Programme for Client Companies A comprehensive business support programme is offered to client companies. This comprises of advice, clinics, seminars and workshops as well as facilitated access to UCD’s world-class researcher community, business leaders, the NovaUCD sponsors, alumni and investors. Workshops and Seminars At NovaUCD a series of workshops, events and seminars are provided monthly and topics are developed based upon client requirements. Workshops cover issues 10

which affect high-potential start-ups such as; raising investment, business development and promotion, finance, product positioning and intellectual property. A specialist NovaUCD Founder’s Club convenes monthly which generates interaction and group discussion around key issues and assists client companies in establishing new networks as part of the NovaUCD community. NovaUCD Mentors and Business Partners Panel The founders of many early-stage NovaUCD client companies and many of the academic promoters of early-stage spin-out companies are actively seeking mentoring from experienced business leaders and entrepreneurs which can be pivotal to the success of a knowledge-intensive or high-technology start-up. NovaUCD has established a Mentors and Business Partners Panel which is aimed at attracting experienced business leaders to preview and engage with business propositions and inventions. The purpose of the panel is to enhance the commercial propositions, to mentor teams, to invest in them or even take the lead as CEO to help successfully bring the ventures to market. €60 million Atlantic Bridge University Bridge Fund This Fund was launched in 2016 following a joint leadership collaboration by UCD, through Brendan Cremen, the then Director of Enterprise and Commercialisation and Trinity. The fund was established to invest in research outputs generated by both universities and all Irish third level institutions and universities. The Fund, managed by Atlantic Bridge, brings together significant institutional investment from the European Investment Fund, its first cornerstone commitment in an Irish fund of this type, Enterprise Ireland, AIB and Bank of Ireland, and by both universities.


5G/IoT Accelerator Programme Vodafone and Ericsson have partnered with NovaUCD to create a new 5G/IoT Accelerator Programme for businesses and start-ups who are planning to develop and bring new 5G/IoT enabled products and services to the market. Participants on this Programme will have the opportunity to develop and enhance their business plans and validate the commercial potential and technical feasibility of new innovative 5G/IoT enabled products and services drawing upon Vodafone and Ericsson’s deep expertise and market knowledge and NovaUCD’s experience in building compelling and investable propositions.

Vodafone, Ericsson and NovaUCD are collaborating on Ireland's first dedicated 5G/IoT accelerator programme. Pictured (l-r) are Tom Flanagan, Director of Enterprise and Commercialisation, UCD; Max Gasparroni, Vodafone Ireland’s Interim CTO; John Griffin, Managing Director, Ericsson Ireland and Anne O’Leary, CEO, Vodafone Ireland.

11


Support Programmes for Researchers and Students NovaUCD offers a range of tailored internships and programmes to UCD researchers and students in the areas of entrepreneurship, innovation, creativity and technology commercialisation. Internship Supports NovaUCD has an ongoing range of internship opportunities, some of which are in collaboration with the UCD Quinn School of Business and the UCD Michael Smurfit Graduate Business School, in areas such as business development and marketing, available to students to work with start-up companies. Such internships give students, who have an interest in entrepreneurship or an ambition to start their own business, a real experience of working in the start-up sector. Sprints/Hackatons The aim of the 1-Day Sprints or hackaton programmes, is to encourage the development of commercial outputs arising from research taking place at UCD by engaging with researchers at an earlier stage in the commercialisation process.

UCD Commercialisation Bootcamp The objective of the UCD Commercialisation Bootcamp is to help equip UCD researchers, staff and postgraduate research students with the knowledge, skills and understanding of the commercialisation process. Bootcamps, run over a number of weeks, take place several times each year and aim to strengthen the pipeline of commercial opportunities arising from UCD research programmes. On completion of the Bootcamp participants have an understanding of what it takes to build a commercialisation plan. It is envisaged that researchers who complete Bootcamps, and whose commercialisation strategy includes the establishment of a spin-out company, may progress to participate on the UCD VentureLaunch Accelerator Programme. UCD Start-up Stars A key support offered by NovaUCD for student entrepreneurs is the UCD Start-up Stars Programme.

Pictured is PhD student Vanessa Ayala-Rivera winner of the 2017 UCD School of Computer Science Sprint Programme with Brendan Cremen, then Director of Enterprise and Commercialisation

12

This entrepreneurship programme has been developed by NovaUCD, the UCD Innovation Academy and UCD Michael Smurfit Graduate Business School, as a framework to support UCD undergraduate and postgraduate students who want to work together to develop and grow start-up companies. The UCD Start-Up Stars Programme begins each year with cross-disciplinary workshops and course modules delivered at UCD Michael Smurfit Graduate Business School and at the UCD Innovation Academy.


During this period students from across the university explore and evaluate a variety of real world problems before forming teams to develop start-up solutions to address the identified problems.

UCD VentureLaunch Accelerator Programme In 2013 NovaUCD introduced a new accelerator programme, VentureLaunch to replace the NovaUCD Campus Company Development Programme.

Student teams then pitch their start-up ideas to a panel of judges who select a small number of early-stage ventures to proceed to the mentoring phase of the programme.

VentureLaunch, which uses the Business Model Canvas approach, is an accelerator programme supporting the creation and launch of sustainable and profitable new ventures based on UCD intellectual property.

The 4-week mentoring programme, held at NovaUCD, consists of a series of structured workshops, taught content from industry experts, interactive workshops as well as regular pitching sessions. In addition there will be opportunities for the teams to network with the NovaUCD community of entrepreneurs.

The objective of the programme is to equip UCD researchers with the knowledge, skills and understanding that will be required to work as part of a team leading a new commercial venture. On completion of the programme the expectation is that participating new venture projects will have developed a commercially viable business plan.

At the final workshop each student venture presents to a final judging panel. Based on evaluation of the presentations and submitted business plans one overall winning team will be selected who will be awarded a cash prize to help them on their start-up journey.

The annual programme ends with a showcase event. The winners of the UCD VentureLaunch Accelerator Programme from 2013 and the winners of the NovaUCD Campus Company Development Programme from 2004 to 2012 are summarised in Appendix 5.

Pictured at NovaUCD are UCD undergraduate students and entrepreneurs, Shane Curran, founder, Evervault and Mark Nealon, founder, myStudyPal

13


Linking with Business and Industry University College Dublin has an international reputation for being at the forefront of innovative research and creative discovery. Bridging the gap between academic research and industry, building relationships and increasing the levels of collaboration with Irish and international industry, are key elements of UCD’s strategy.

Companies, ranging from early-stage high-tech start-ups to more established innovation-led companies, also locate on campus in order to collaborate more closely with UCD and to be located in close proximity to UCD’s world-class research base. Examples of linking with industry and business include;

The university has a strong track record of working with industry and seeks strong and strategic engagement with business, social and cultural enterprises; adding value, expanding networks and exploring new opportunities to deliver impact through partnership.

Pictured (l-r) are UCD engineering students; Sarah Brady, Anthony Newell and Axieh Bagaso using an automated football factory demo donated to the university by Maxim Integrated Products Inc

Our innovation ecosystem includes large-scale industry collaborative programmes such as; SFI Research Centres and Enterprise Ireland-funded and industry-led technology centres. In addition over 250 companies have funded research at UCD in recent years and more than 1,000 companies have also collaborated with UCD on research projects.

14

R&D Collaboration NovaUCD assists companies who want to collaborate and benefit from UCD’s research expertise by partnering with the university on small or large research projects. For example UCD is working with a number of companies, on a range of R&D projects focused on 'disruptive' technologies which are being supported by the Government through the Disruptive Technology Innovation Fund. These companies include; Amryt Pharma, Curran Scientific Ltd, Davra Networks Ltd, DEBRA Ireland, Deciphex, Exertis Supply Chain Services, IBM, IdentiGEN, Nova Leah and Sonalake. Licensing Opportunities NovaUCD has a growing portfolio of licence deals which will benefit the companies to whom the technology is licensed by making them more competitive, create new products, scale, generate employment and hopefully, with time, provide financial returns to the university and the inventors. As an example Amryt, the Irish-listed biopharma company, which focuses on rare or ‘orphan’ diseases, completed an in-licence agreement with UCD. This will see the company working with the university on a novel gene therapy platform that could prove immeasurably beneficial to the lives of those living with epidermolysis bullosa (EB), a rare and debilitating skin disorder.


ConsultUCD ConsultUCD, the university’s managed consultancy service based at NovaUCD, facilitates access and supports engagement between business, industry and the university. Since it was established in 2017 UCD academic consultants have worked with a variety of organisations including pharmaceutical companies, charities, Irish and UK SMEs, accountancy and legal firms. As an example, Toyota Ireland, through ConsultUCD, commissioned a number of university researchers to carry out a study on the energy behaviour of Toyota Prius hybrid vehicles in a sample of commuting conditions in Ireland. ConsultUCD also actively engages with industry and business to develop consultancy opportunities. Such opportunities will enable UCD expertise deliver economic and societal benefit in Ireland and internationally by enabling the UCD’s knowledge and expertise to be more widely and more easily accessible to external stakeholders.

Key findings of a UCD study were that Toyota’s hybrid powertrain system drives in zero emissions mode (ZEV) for significantly more than half (62%) of the time and over 40% of the distance covered

Pictured (l-r) are Assistant Professor Emmanuel G. Reynaud and Professor Brian Rodriguez, Naiad, winner of the 2018 UCD VentureLaunch Accelerator Programme 15


Knowledge Transfer The Knowledge Transfer team based at NovaUCD, through its extensive commercial experience and drawing on a network of industry experts, patent agents and legal experts, supports UCD researchers to commercially exploit research outputs for the benefit of the university and the wider community. UCD’s knowledge transfer operations are partially supported with funding provided by Enterprise Ireland under the Technology Transfer Strengthening Initiative, managed by Knowledge Transfer Ireland. Identifying, Protecting and Commercialising Intellectual Property UCD has a structured approach to ensure that intellectual property is identified and appropriately protected. Members of the knowledge transfer team regularly meet with UCD researchers to provide advice on commercial aspects of research proposals and contracts, to monitor the progress of research projects, to provide appropriate assistance to the researchers at the different stages of their research projects, and to remind researchers of UCD’s contractual obligations to funding agencies and companies, and implement UCD’s policy on intellectual property. The knowledge transfer team is responsible for ensuring that the intellectual property terms on ownership and access rights reflect the objectives of the project, do not conflict with any other agreements that the university has entered into, comply with State Aid Rules, the requirements of the Funding Agency Guidelines and National Codes of Practice, and importantly preserve wherever possible the researchers right to publish and use the intellectual property in future research projects.

NovaUCD has introduced a number of new initiatives, including in-hospital knowledge transfer offices and KT Scouts, to support knowledge transfer activities across the wider UCD ecosystem. In-Hospital Knowledge Transfer Offices NovaUCD has established Ireland’s first in-hospital Knowledge Transfer Offices in partnership with St. Vincent’s Healthcare Group and The Mater Misericordiae University Hospital. Both of these in-hospital Knowledge Transfer Offices were established by NovaUCD to develop the commercial potential of the research outputs emerging from both hospitals and to extend the reach of their medical advancements to a greater number of patients worldwide. KT Scouts The aim of the KT Scout Initiative is to foster and build a community of selected postdoctoral fellows, PhD students and research administrators who are interested in learning more about the commercialisation of technology. The scouts will learn more by assisting the knowledge transfer team in identifying new commercial opportunities within their own Colleges, Schools and Institutes. NovaUCD Innovation Award The NovaUCD Innovation Award was established in 2004 and is presented annually to an individual, company or organisation or group in recognition of excellence in innovation or of success achieved in the commercialisation of UCD research or other intellectual activity. Recipients of this award since 2004 are highlighted in Appendix 6.

16


Pictured is Professor Brian Caulfield, UCD School of Public Health, Physiotherapy and Sports Science, recipient of the 2017 NovaUCD Innovation Award

17


Staff Members Professor Orla Feely is UCD’s Vice-President for Research, Innovation and Impact. The members of the NovaUCD team, and their contact details are given below.

18

Name

Position

Tel: + 353-1-

Email:

Professor Orla Feely

Vice-President for Research, Innovation and Impact

716 4031

vprii@ucd.ie

Tom Flanagan

Director of Enterprise and Commercialisation

716 3718

tom.flanagan@ucd.ie

Jackie Boyd-Lyons

PA/Business Support Executive

716 3710

jackie.boydlyons@ucd.ie

Dr Ciaran O’Beirne

Manager, Knowledge Transfer

716 3713

ciaran.obeirne@ucd.ie

Dr Tony Donnelly

Case Manager, Knowledge Transfer

716 3727

tony.donnelly@ucd.ie

Dr Stephen Donoghue

Case Manager, Knowledge Transfer

716 3720

stephen.donoghue@ucd.ie

Dr Hugh Hayden

Case Manager, Knowledge Transfer

716 3725

hugh.hayden@ucd.ie

Dr Stacey Kelly

Case Manager, Knowledge Transfer

716 3705

stacey.kelly@ucd.ie

Dr Ena Walsh

Case Manager, Knowledge Transfer

716 3706

ena.walsh@ucd.ie

John Wrigley

Administrative Assistant, Knowledge Transfer

716 3721

john.wrigley@ucd.ie

Helen Mc Grath

Operations Manager

716 3711

helen.mcgrath@ucd.ie

Thomas Hamill

Facilities Manager

716 3717

tom.hamill@ucd.ie

Simon Factor

Senior Manager, New Ventures

716 3728

simon.factor@ucd.ie

Caroline Gill

Innovation Education Manager

716 3715

caroline.gill@ucd.ie

Elizabeth Nolan

Head, ConsultUCD

716 3714

elizabeth.nolan@ucd.ie

Marian O’Dea

Consultancy Services Executive

716 3707

marian.odea@ucd.ie

Michelle Doyle

Research and Innovation Engagement Manager

716 3716

michelle.doyle@ucd.ie

Micéal Whelan

Communications Manager

716 3712

miceal.whelan@ucd.ie


Location and Directions The vehicular entrance to NovaUCD is located on Fosters Avenue, approximately 200m from the Stillorgan dual carriageway (N11). The road from this gate leads directly towards NovaUCD. Limited car parking is available to visitors to NovaUCD. Charges for visitor parking apply from 8:00 am to 5:00 pm, Monday to Friday (excluding bank holidays) during semester times. Outside of these hours and outside of semester time parking is free on a first-come-first-serve basis.

NovaUCD Reception: The NovaUCD reception can be contacted via t: + 353-1-716 3700 or e: nova.reception@ucd.ie.

Contact Details: UCD Research and Innovation NovaUCD, Belfield Innovation Park University College Dublin, Belfield Dublin 4, Ireland. t: + 353-1-716 3700 e: innovation@ucd.ie w: www.novaucd.ie

For further information contact: MicĂŠal Whelan Communications Manager UCD Research and Innovation NovaUCD Belfield Innovation Park University College Dublin Belfield, Dublin 4, Ireland. t: + 353-1-716 3712 e: miceal.whelan@ucd.ie

Social Media: @NovaUCD www.facebook.com/UCDinnovation www.youtube.com/ucdinnovation www.linkedin.com/company/novaucd/

19


Appendix 1: Timeline of Key Milestones

1985

University Industry Centre opened as a focal point for UCD-industry co-operation

2011

BiancaMed, a UCD spin-out, acquired by ResMed in a multi-million dollar deal

1988

Dr Pat Frain appointed Director of the University Industry Programme

2013

UCD VentureLaunch Accelerator Programme replaces the Campus Company Development Programme

1989

Campus Innovation Centre established at Roebuck Castle 2015

Logentries, a UCD spin-out, acquired by Rapid7, for $68 million

1996

Campus Company Developed Programme established

2003

NovaUCD, the Centre for New Ventures and Entrepreneurs opened

2004

First NovaUCD Innovation Award presented

2007

Funding received under the first round of Enterprise Ireland’s Technology Transfer Strengthening Initiative (TTSI)

First UCD Start-Up Stars Programme completed 2016

€60 million Atlantic Bridge University Bridge Fund established

2017

ConsultUCD, UCD’s managed consultancy service established

2018

Ireland’s first in-hospital Knowledge Transfer Offices opened €6.5 million development project to renovate and extend NovaUCD’s east courtyard announced

Licence of BSE or ‘mad cow disease’ test reaches €2 million royalty income mark 2008

20

ChangingWorlds, a UCD spin-out, acquired by Amdocs for €65 million+

2019

Ireland’s first dedicated 5G/IoT accelerator programme opened for applications


Pictured (l-r) are; Danila Fedotov, Cork; Jennifer McCarthy, Cork; Michael Kirby, Kerry; Roisin O'Connor, Offaly; and Jack O'Connor, Limerick, overall winners of the 10th annual BTYSTE Business Bootcamp run by BT Ireland and NovaUCD.

21


Appendix 2: Success Stories Kinesis Health Technologies

VRM Tech

Kinesis Health Technologies, co-founded by Seamus Small and Dr Barry Greene is a digital health spin-out from the Technology Research for Independent Living (TRIL) Centre, a research programme, at UCD, TCD and St James’s Hospital.

VRM Tech, co-founded by Neill Ryan, Eoin McGuckian and Ronan McNulty is a NovaUCD spin-in company. VRM Tech is disrupting the construction industry with innovative software solutions for the built environment including energy performance management, construction compliance, technical monitoring and visualisations of sensing technologies.

Kinesis products help prevent falls in older adults by using wearable sensor technologies, enabling older adults to remain independent and reducing healthcare costs. Falls in older adults are a serious global problem, costing $50 billion each year in the US alone. The WHO estimates that 30% of adults, over 65 years of age, fall at least once each year. Ageing is one of the great global challenges, and innovation is essential in bringing measurable impact to this challenge. Kinesis’ technology brings real measurability to one of the most critical factors in ageing, the risk of falls. Kinesis QTUG™, a Class I medical device, based on 10 years of research, is used by healthcare professionals to identify those patients at risk of falls and to prescribe an intervention, to quantify a patient’s response to therapy and rehabilitation, and to assess patients with neurological disorders. Kinesis, founded in 2013 is now a team of seven and is currently based in NexusUCD, the Industry Partnership Centre. The company is a great example of how UCD’s commercialisation agenda brings relevant discoveries and intellectual property from the university to highly competitive markets.

22

“Kinesis has received great support from NovaUCD over the years. The initial support in securing commercialisation funding then going through and winning the UCD VentureLaunch Accelerator Programme in 2013 through to building out our team at NexusUCD we appreciate the continued professional support and advice provided.” Seamus Small, CEO, co-founder, Kinesis Healthcare Technologies.

Since the company formed, it has grown from a team of 3 to 15 employees with offices in both the UK and Dublin and has an impressive list of influential clients including London’s Camden Council, Croydon Council, Greater London Authority and Barnett Council. VRM has worked on multiple EU and UK government backed construction research projects. They have been at the forefront of Horizon 2020’s Built2Spec initiative in developing technological breakthroughs that both simplify and expedite the process for new builds and retrofits in meeting EU energy efficiency targets.

“Being in close proximity to and having facilitated access to UCD’s research expertise has been a valuable resource for us and one of the key reasons we decided to locate at NovaUCD.” Neill Ryan, CEO, VRM Tech.


Carrick Therapeutics

Logentries

Carrick Therapeutics, an early-stage lifesciences enterprise is a NovaUCD spin-in company which aims to build Europe’s leading oncology company.

Logentries co-founded in 2010 by Dr Trevor Parsons and Dr Viliam Holub as a UCD spin-out company from UCD’s Performance Engineering Laboratory after a decade of joint research with IBM. Based on the simple premise that there was tremendous value to businesses hidden within log data entries, Logentries developed a SaaS based, log management service for collecting and analyzing big data and making this data easily accessible to improve IT and business operations.

Carrick Therapeutics has an ambitious patient focused vision to serve cancer patients around the world with ground breaking cancer therapies that will transform the way cancer is treated. The company is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Carrick Therapeutics, in an initial funding round raised €84.5 million from investors including Arch Venture Partners, one of the largest early-stage technology venture firms in the US, Woodford Investment Management, Cambridge Enterprise Seed Funds, Cambridge Innovation Capital, Evotec, Google Ventures and Lightstone Ventures. In 2018 Dr Elaine Sullivan, co-founder and CEO won the EY Emerging Entrepreneur of The YearTM (EOY) Award.

By 2013, the company had secured $10 million in Series A funding, the largest single investment round in a UCD spinout and were servicing tens of thousands of users in over 100 countries, and appointed Andrew Burton as CEO. Of all the cloud–based start-ups Logentries’ progress was particularly speedy and two years later, Rapid7, a leading US provider of security data and analytics solutions acquired Logentries for over €68 million. The acquisition of Logentries’ world-class machine data search technology enabled Rapid7’s information security teams to solve a full range of security challenges, deeply investigate incidents and more efficiently achieve their compliance requirements. The company, originally based and supported at NovaUCD, came through the UCD VentureLaunch Accelerator Programme and Logentries credits NovaUCD as being very valuable in helping them to define and transform their ideas into a commercially feasible enterprise.

23


OXYMEM OxyMem, an Irish cleantech company, is a spin-out from the UCD School of Chemical and Bioprocess Engineering and was co-founded by Wayne Byrne, Professor Eoin Casey and Dr Eoin Syron. The Irish wastewater start-up is a leading innovator in energy efficient wastewater treatment. OxyMem’s breakthrough technology addresses the global need for a more energy efficient wastewater treatment, a worldwide challenge that consumes over 2% of a nation’s electricity production.

“To be able to use the NovaUCD brand carries weight when you’re talking to investors and customers alike.” Dr Viliam Holub, co-founder, Logentries.

Membrane-Aerated Biofilm Reactor (MABR), developed by OxyMem, is the breakthrough technology that focuses on wastewater aeration. This makes the treatment process 75% more energy efficient than conventional treatment technology. Conventional aeration systems have relied on a very energy intensive process known as bubble aeration which has remained unchanged for nearly 100 years. OxyMem is one of a few companies in the world that can offer both process and operational advantages to the wastewater treatment sector which is estimated to be worth over €30 billion. OxyMem has an impressive list of clients in Ireland, UK, Spain, Sweden, Japan, Middle East, Canada and Brazil and is currently in the process of growing the company’s number of employees from 25 to 50.

24

"We have evolved quite significantly since we were set-up and the facilities, supports and services provided at NovaUCD certainly made it easy to for us to concentrate on growing the company." Wayne Byrne, CEO, co-founder, OxyMem.


NovaUCD was funded by a unique public-private partnership which includes; AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx.

25


Appendix 3: Client Companies Client companies include: Allsorter Aquens Atturos ATXA Therapeutics Auranta Berand Bioplastech Biosensia Bláfar Brightwind Carrick Therapeutics

CoalFace Capital Empiric Logic EPIC Conjoint Equilume Evervault GB Innovation Genebox Iamus Technologies Initiative Ireland Innovation Zed Kelada

Pictured (l-r) are the founders of Output Sports, Dr Martin O’Reilly, Dr Darragh Whelan and Julian Eberle

Latch Medical Manna myStudyPal Nova Mentis Nsilico O.C.E. Technology OncoMark Output Sports Parameter Space PlasmaBound Profcal

Pictured (l-r) are; Dawn Walsh, Kernel Capital; Des O’Leary, CEO, OncoMark; Professor William Gallagher, Director, UCD Conway Institute and co-founder, OncoMark; Deirdre Glenn, Manager, Lifesciences Sector, Enterprise Ireland and Kevin Healy, Senior Manager, Corporate Banking Ireland, Bank of Ireland

ProvEye SiriusXT Terra Solar THEYA Healthcare This is Seaweed TravaCoin Vivid Edge VRM Tech Zeeko 4Property

Pictured (l-r) are; Cyrille Vigneron, President and Chief Executive of Cartier; Ciara Donlon, Founder and CEO, THEYA Healthcare; and Ilian Mihov, Dean of Insead.

Note: NovaUCD is also responsible for supporting the wider UCD entrepreneurial ecosystem of companies which includes those based at NexusUCD, the Industry Partnership Centre; spin-out companies based on and off campus; and spin-in companies based elsewhere on campus.

26


Appendix 4: Alumni Companies NovaUCD alumni companies include: AccountsIQ Aficionado Technologies Aonta Technologies BiancaMed BioMerieux Cernam ChangingWorlds Connectors Marketplace Corlytics DocoSOFT

Duolog Technologies ENBIO Endura Technologies EnvEcon Enzolve Technologies Equinome Eventznet Finalysis GMI gsmExchange.com

Pictured is Professor Emmeline Hill, co-founder of Equinome, a UCD spin-out company acquired by Plusvital

Hemanua HiTech Health Home Instead Innovios Ionic Java Clinical Research Locumotion Logentries MagGrow MyWallSt

Pictured is Wayne Byrne, CEO, co-founder, OxyMem, SME Category Winner, 2018 US-Ireland Research Innovation Awards

Neuromod Devices NovoGrid Nuritas OxyMem Plusvital Restored Hearing Talentevo Voucherpages Wattics

Pictured are John Tyrrell and Emmet Savage, co-founders, MyWallSt (formerly Rubicoin)

27


Appendix 5: Winners of the UCD VentureLaunch Accelerator Programme 2018

Naiad, Assistant Professor Emmanuel G. Reynaud, UCD School of Biomolecular and Biomedical Science and Professor Brian Rodriguez, UCD School of Physics

2017

Prolego Scientific, Professor Andrew Parnell, Dr Belinda Hernández and Dr Mahdi Amina, UCD School of Mathematics and Statistics

2016

AzaCor Therapeutics, Associate Professor John Baugh, Dr Nadia Glezeva, Dr Chris Watson, Dr Mark Ledwidge and Professor Ken McDonald, UCD School of Medicine

2015

2014

2011

APC, Professor Brian Glennon and Dr Mark Barrett, UCD School of Chemical and Bioprocess Engineering

2010

Logentries, Dr Trevor Parsons and Dr Viliam Holub, UCD School of Computer Science

2009

Equinome, Associate Professor Emmeline Hill, UCD School of Agriculture and Food Science

2008

RendezVu (ASimil8), Paul Groarke and Garrett Hussey, a UCD spin-in company

Phision Therapeutics, Dr Breandán Kennedy and Dr Alison Reynolds, UCD School of Biomolecular and Biomedical Science

2007

EnvEcon, Professor Peter Clinch and Dr Andrew Kelly, UCD School of Architecture, Planning and Environmental Policy

NovoGrid, Professor Andrew Keane and Dr Peter Richardson, and Paul Manning, UCD School of Electrical and Electronic Engineering

2006

FitFone, Dr Conor O’Brien, Royal College of Surgeons in Ireland

2013

Kinesis Health Technologies, Dr Barry Greene and Seamus Small, UCD School of Public Health, Physiotherapy and Sports Science

2005

Vocal Health Screen, Rosalyn Moran, PhD student, UCD School of Electrical and Electronic Engineering

2012

PurOrigin, Finbarr Maguire and David Ronan, Masters of Engineering students, UCD School of Mechanical and Materials Engineering

2004

Nanosense, Dr Margaret Brennan, School of Physics, Trinity College Dublin

Note: Programme known as the Campus Company Development Programme (CCDP) from 2004 until 2013. In the early years of the CCDP, projects from other third-level institutions in Dublin participated on this programme.

28


Pictured (l-r) are Professor Andrew Keane, Paul Manning and Dr Peter Richardson, NovoGrid, winner 2014 UCD VentureLaunch Accelerator Programme

29


Appendix 6: Recipients of the NovaUCD Innovation Award 2018

Professor Stephen Pennington, UCD School of Medicine

2011

Professor William Gallagher, UCD School of Biomolecular and Biomedical Science

2017

Professor Brian Caulfield, UCD School of Public Health, Physiotherapy and Sports Science

2010

The Fault Analysis Group, UCD School of Earth Sciences

2009

Nicola Mitchell, founder, Life Scientific, a UCD spin-in company

2016

Professor Kevin O’Connor, UCD School of Biomolecular and Biomedical Science

2008

Celtic Catalysts, a UCD spin-out company

2015

Professor Eoin Casey and Dr Eoin Syron, UCD School of Chemical and Bioprocess Engineering, co-founders, OxyMem

2007

Professor Ciaran Regan, UCD School of Biomolecular and Biomedical Science

Professor Emmeline Hill, UCD School of Agriculture and Food Science, co-founder, Equinome

2006

Professor Conor Heneghan, UCD School of Electrical and Electronic Engineering

Dr Trevor Parsons and Dr Viliam Holub, UCD School of Computer Science, co-founders, Logentries

2005

Professor Barry Smyth, UCD School of Computer Science

2004

Professor Mark Rogers, UCD Registrar and Deputy President

2014

2013

2012

30

Professor Denis Dowling, UCD School of Chemical and Bioprocess Engineering and UCD School of Mechanical and Materials Science


Pictured is Nicola Mitchell, founder, Life Scientific, recipient of the 2009 NovaUCD Innovation Award

31


NovaUCD is supported by:


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.